(2016). Effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve HIV-infected patients: A nonrandomized, open-label, phase IV study in Cali-Colombia, 2011-2012.
Chicago Style (17th ed.) CitationEffectiveness and Safety of Generic Version of Abacavir/lamivudine and Efavirenz in Treatment Naïve HIV-infected Patients: A Nonrandomized, Open-label, Phase IV Study in Cali-Colombia, 2011-2012. 2016.
MLA (8th ed.) CitationEffectiveness and Safety of Generic Version of Abacavir/lamivudine and Efavirenz in Treatment Naïve HIV-infected Patients: A Nonrandomized, Open-label, Phase IV Study in Cali-Colombia, 2011-2012. 2016.
Warning: These citations may not always be 100% accurate.